NCT03450772View on ClinicalTrials.gov

Equivalence Study to Compare Two Strengths of Creon in China

PHASE3UnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions

Pancreatic Insufficiency

Interventions

DRUG

Creon® 25000

Experimental drug

DRUG

Creon® 10000

Active comparator

Trial Locations (1)

Unknown

RECRUITING

Shanghai Changhai Hospital, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY